BRCA2 Localization to the Midbody by Filamin A Regulates CEP55 Signaling and Completion of Cytokinesis

Developmental Cell

Volumn 23, Issue 1, 2012, Pages 137-152

  Mondal, Gourish ^a   Rowley, Matthew ^a   Guidugli, Lucia ^a   Wu, Jianmin ^a   Pankratz, Vernon S ^a   Couch, Fergus J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; CELL CYCLE PROTEIN; ESCRT PROTEIN; FILAMIN A; MULTIPROTEIN COMPLEX; PROTEIN ALIX; PROTEIN CEP55; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; CYTOKINESIS; DNA DAMAGE; DNA REPAIR; HUMAN; HUMAN CELL; MOUSE; NEOPLASM; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECOMBINATION REPAIR; SIGNAL TRANSDUCTION;

ANIMALS; BRCA2 PROTEIN; CELL CYCLE PROTEINS; CONTRACTILE PROTEINS; CYTOKINESIS; DNA-BINDING PROTEINS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; FEMALE; HEK293 CELLS; HELA CELLS; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, MUTANT STRAINS; MICROFILAMENT PROTEINS; NUCLEAR PROTEINS; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84863994580     PISSN: 15345807     EISSN: 18781551     Source Type: Journal    
DOI: 10.1016/j.devcel.2012.05.008     Document Type: Article

References (32)

1. Carlton J.G., Martin-Serrano J. Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. Science 2007, 316:1908-1912.
2. Cunningham C.C., Gorlin J.B., Kwiatkowski D.J., Hartwig J.H., Janmey P.A., Byers H.R., Stossel T.P. Actin-binding protein requirement for cortical stability and efficient locomotion. Science 1992, 255:325-327.
3. Daniels M.J., Wang Y., Lee M., Venkitaraman A.R. Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2. Science 2004, 306:876-879.
4. Fabbro M., Zhou B.B., Takahashi M., Sarcevic B., Lal P., Graham M.E., Gabrielli B.G., Robinson P.J., Nigg E.A., Ono Y., Khanna K.K. Cdk1/Erk2- and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis. Dev. Cell 2005, 9:477-488.
5. Farrugia D.J., Agarwal M.K., Pankratz V.S., Deffenbaugh A.M., Pruss D., Frye C., Wadum L., Johnson K., Mentlick J., Tavtigian S.V., et al. Functional assays for classification of BRCA2 variants of uncertain significance. Cancer Res. 2008, 68:3523-3531.
6. Feng Y., Walsh C.A. The many faces of filamin: a versatile molecular scaffold for cell motility and signalling. Nat. Cell Biol. 2004, 6:1034-1038.
7. Ganem N.J., Godinho S.A., Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature 2009, 460:278-282.
8. Gromley A., Yeaman C., Rosa J., Redick S., Chen C.T., Mirabelle S., Guha M., Sillibourne J., Doxsey S.J. Centriolin anchoring of exocyst and SNARE complexes at the midbody is required for secretory-vesicle-mediated abscission. Cell 2005, 123:75-87.
9. Iwamori T., Iwamori N., Ma L., Edson M.A., Greenbaum M.P., Matzuk M.M. TEX14 interacts with CEP55 to block cell abscission. Mol. Cell. Biol. 2010, 30:2280-2292.
10. Jonsdottir A.B., Vreeswijk M.P., Wolterbeek R., Devilee P., Tanke H.J., Eyfjörd J.E., Szuhai K. BRCA2 heterozygosity delays cytokinesis in primary human fibroblasts. Cell. Oncol. 2009, 31:191-201.
11. Kurasawa Y., Earnshaw W.C., Mochizuki Y., Dohmae N., Todokoro K. Essential roles of KIF4 and its binding partner PRC1 in organized central spindle midzone formation. EMBO J. 2004, 23:3237-3248.
12. Lee H.H., Elia N., Ghirlando R., Lippincott-Schwartz J., Hurley J.H. Midbody targeting of the ESCRT machinery by a noncanonical coiled coil in CEP55. Science 2008, 322:576-580.
13. Lee M., Daniels M.J., Garnett M.J., Venkitaraman A.R. A mitotic function for the high-mobility group protein HMG20b regulated by its interaction with the BRC repeats of the BRCA2 tumor suppressor. Oncogene 2011, 30:3360-3369.
14. Lekomtsev S., Guizetti J., Pozniakovsky A., Gerlich D.W., Petronczki M. Evidence that the tumor-suppressor protein BRCA2 does not regulate cytokinesis in human cells. J. Cell Sci. 2010, 123:1395-1400.
15. Liu J., Yuan Y., Huan J., Shen Z. Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2. Oncogene 2001, 20:336-345.
16. Matuliene J., Kuriyama R. Kinesin-like protein CHO1 is required for the formation of midbody matrix and the completion of cytokinesis in mammalian cells. Mol. Biol. Cell 2002, 13:1832-1845.
17. McCullagh P., Nelder J.A. Generalized Linear Models, Second Edition, Chapter 10 1989, Chapman and Hall, London.
18. Mollinari C., Kleman J.P., Saoudi Y., Jablonski S.A., Perard J., Yen T.J., Margolis R.L. Ablation of PRC1 by small interfering RNA demonstrates that cytokinetic abscission requires a central spindle bundle in mammalian cells, whereas completion of furrowing does not. Mol. Biol. Cell 2005, 16:1043-1055.
19. Morita E., Sandrin V., Chung H.Y., Morham S.G., Gygi S.P., Rodesch C.K., Sundquist W.I. Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis. EMBO J. 2007, 26:4215-4227.
20. Nunnally M.H., D'Angelo J.M., Craig S.W. Filamin concentration in cleavage furrow and midbody region: frequency of occurrence compared with that of alpha-actinin and myosin. J. Cell Biol. 1980, 87:219-226.
21. Playford M.P., Lyons P.D., Sastry S.K., Schaller M.D. Identification of a filamin docking site on PTP-PEST. J. Biol. Chem. 2006, 281:34104-34112.
22. Prekeris R., Gould G.W. Breaking up is hard to do-membrane traffic in cytokinesis. J. Cell Sci. 2008, 121:1569-1576.
23. Ryser S., Dizin E., Jefford C.E., Delaval B., Gagos S., Christodoulidou A., Krause K.H., Birnbaum D., Irminger-Finger I. Distinct roles of BARD1 isoforms in mitosis: full-length BARD1 mediates Aurora B degradation, cancer-associated BARD1beta scaffolds Aurora B and BRCA2. Cancer Res. 2009, 69:1125-1134.
24. Sakai W., Swisher E.M., Jacquemont C., Chandramohan K.V., Couch F.J., Langdon S.P., Wurz K., Higgins J., Villegas E., Taniguchi T. Functional restoration of BRCA2 protein by secondary BRCA2 mutations in BRCA2-mutated ovarian carcinoma. Cancer Res. 2009, 69:6381-6386.
25. Sakai W., Swisher E.M., Karlan B.Y., Agarwal M.K., Higgins J., Friedman C., Villegas E., Jacquemont C., Farrugia D.J., Couch F.J., et al. Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers. Nature 2008, 451:1116-1120.
26. Steigemann P., Wurzenberger C., Schmitz M.H., Held M., Guizetti J., Maar S., Gerlich D.W. Aurora B-mediated abscission checkpoint protects against tetraploidization. Cell 2009, 136:473-484.
27. Vinciguerra P., Godinho S.A., Parmar K., Pellman D., D'Andrea A.D. Cytokinesis failure occurs in Fanconi anemia pathway-deficient murine and human bone marrow hematopoietic cells. J. Clin. Invest. 2010, 120:3834-3842.
28. Wang H.F., Takenaka K., Nakanishi A., Miki Y. BRCA2 and nucleophosmin coregulate centrosome amplification and form a complex with the Rho effector kinase ROCK2. Cancer Res. 2011, 71:68-77.
29. Wu K., Hinson S.R., Ohashi A., Farrugia D., Wendt P., Tavtigian S.V., Deffenbaugh A., Goldgar D., Couch F.J. Functional evaluation and cancer risk assessment of BRCA2 unclassified variants. Cancer Res. 2005, 65:417-426.
30. Yang H., Jeffrey P.D., Miller J., Kinnucan E., Sun Y., Thoma N.H., Zheng N., Chen P.L., Lee W.H., Pavletich N.P. BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science 2002, 297:1837-1848.
31. Yuan Y., Shen Z. Interaction with BRCA2 suggests a role for filamin-1 (hsFLNa) in DNA damage response. J. Biol. Chem. 2001, 276:48318-48324.
32. Zhao W.M., Seki A., Fang G. Cep55, a microtubule-bundling protein, associates with centralspindlin to control the midbody integrity and cell abscission during cytokinesis. Mol. Biol. Cell 2006, 17:3881-3896.